UnitLevel 2Undergraduate

PHR2142 Comprehensive care: Cardiovascular

Faculty of Pharmacy and Pharmaceutical Sciences

PHR2142 Comprehensive care: Cardiovascular is a level 2, 6-credit-point, undergraduate unit from the Faculty of Pharmacy and Pharmaceutical Sciences, offered in 2026 in Semester 2 at Malaysia and Parkville. It needs PHR2041, PHR2141, PHR1122, PHR1222, PHR1011, PHR1021, PHR1031, PHR1012, PHR2011, PHR1022 and PHR2021 and unlocks 10 units, leading on to 11 units in all.

Credit points
6
Offered in 2026
Semester 2
Malaysia, Parkville
Assessment
Exam 50%
and 3 other tasks

This is the 2026 handbook entry. See the 2027 entry.

Reviews

No reviews yet

No reviews yet. Be the first to review PHR2142.

Requisites

Overview

This unit provides the knowledge and skills required for the diagnosis and therapeutic management of patients with cardiovascular conditions. Specifically, the unit will cover cardiovascular diseases and disorders such as hypertension, dyslipidaemia, heart failure, and atherosclerosis and thromboembolic disorders. This unit will relate the pathophysiology and epidemiology of these conditions with the rational design and clinical use of medicines. The chemistry, pharmacology, disposition, and clinical and therapeutic aspects of medicines associated with each condition are presented in an integrated fashion. This unit will involve the development of pharmacy relevant skills such as medication-related clinical problem solving and decision making, critical thinking and oral and written communication skills. Drug therapy principles for treating cardiovascular conditions will be emphasised, enabling you to acquire the skills necessary to optimise medication adherence and improve treatment outcomes across diverse, complex patient cases and cultural contexts.

Offerings in 2026

Teaching periodCampusMode
Second semesterMalaysiaOn campus
Second semesterParkvilleBlended

Assessment

  • In-semester testsQuiz / TestCompetency hurdle
    20%
  • Oral communication assessmentsPresentation
    5%
  • Workshop and Applied session assessmentsWritten
    25%
  • Final ExaminationExamination
    50%

Assessment details may change. Please refer to the assessment information in Moodle closer to the start of the teaching period.

Learning outcomes

When you finish this unit, you should be able to:

  1. 1

    Describe how the structure and function of the cardiovascular system is affected by disease

  2. 2

    Describe the epidemiology and clinical aspects of disease state management for selected cardiovascular conditions, including primary and secondary prevention strategies

  3. 3

    Describe the signs and symptoms, and identify diagnostic methods used to detect cardiovascular conditions

  4. 4

    Explain the mechanism of action of drugs used in treatment of selected cardiovascular conditions, and predict their therapeutic effects  and potential side effects based on these mechanisms

  5. 5

    Identify and prioritise pharmacological  and non-pharmacological treatment options for the management of acute and chronic cardiovascular conditions

  6. 6

    Evaluate a patient's cardiovascular condition and create a patient specific care plan which applies established clinical guidelines, incorporating a comprehensive clinical review of potential drug-related problems

  7. 7

    Evaluate and justify when referral for medical assessment is required, with a particular emphasis on symptoms indicative of referral

  8. 8

    Apply counselling strategies that provide support and optimise behavioural change for patients with cardiovascular conditions

  9. 9

    Using a multidisciplinary healthcare team approach, develop and articulate appropriate clinical and communication strategies to treat cardiovascular conditions

Workload and teaching

  • Assessments2 hours
  • Applied sessions24 hours
  • Workshops24 hours
  • Teaching approachCase-based teaching
  • Teaching approachPeer assisted learning
  • Teaching approachOnline learning
  • Teaching approachEnquiry-based learning
  • Teaching approachActive learning
  • Seventy-two hours of independent study
  • Twenty-four hours of pre-learning activities (up to 4 hours per week for 6 weeks)
  • Twenty-four hours of active learning applied sessions (4 hours per week for 6 weeks)
  • Twenty-four hours of small group classes including assessment (4 hours per week for 6 weeks)

Learning resources

Required resources

Therapeutic guidelines

Australian Medicines handbook (AMH)

MIMS Online

Australian Pharmaceutical Formulary (APF)

Technology resources

For more information on Bring Your Own Device (BYOD) specifications and the technology systems and services available to students, review the Student Technology Essentials Handbook https://www.monash.edu/__data/assets/pdf_file/0010/1041220/student-it-brochure.pdf

Contacts

Unit Coordinators
Dr Suzanne Caliph
Dr Yogaambikai Paramanantham
Chief Examiners
Dr Suzanne Caliph

Common questions

What are the prerequisites for PHR2142?

You need PHR2041, PHR2141, PHR1122, PHR1222, PHR1011, PHR1021, PHR1031, PHR1012, PHR2011, PHR1022 and PHR2021 before you enrol.

What can I take after PHR2142?

PHR2142 is a prerequisite or corequisite for 10 units, including PHR3041, PHR3042, PHR3062, PHR3141, PHR4012 and PHR4042. Those lead on to 11 units in all.

When is PHR2142 offered?

In 2026, PHR2142 runs in Semester 2 at Malaysia and Parkville.

Does PHR2142 have an exam?

Yes. The exam is worth 50% of the final mark, alongside 3 other tasks.

More details

Credit points
6
Level
2
Study level
Undergraduate
Faculty
Faculty of Pharmacy and Pharmaceutical Sciences
Type
Coursework
EFTSL
0.125
Student contribution
SCA Band 2
Study abroad
Not available